A Dose-Finding Study To Compare The Safety, Tolerability, And Efficacy Of Differing Dosing Regimens Of ISV-101 (Bromfenac In DuraSite Ophthalmic Solution) To Vehicle And DuraSite Alone In Dry Eye Disease Volunteers

Trial Profile

A Dose-Finding Study To Compare The Safety, Tolerability, And Efficacy Of Differing Dosing Regimens Of ISV-101 (Bromfenac In DuraSite Ophthalmic Solution) To Vehicle And DuraSite Alone In Dry Eye Disease Volunteers

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Bromfenac (Primary)
  • Indications Dry eyes
  • Focus Adverse reactions
  • Sponsors InSite Vision
  • Most Recent Events

    • 30 Aug 2016 Planned End Date changed from 1 Jan 2018 to 1 Jan 2019.
    • 30 Aug 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jul 2018.
    • 30 Aug 2016 Planned initiation date changed from 1 Jan 2017 to 1 Jan 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top